|
1
|
Seropian IM, Toldo S, Van Tassell BW and
Abbate A: Anti-inflammatory strategies for ventricular remodeling
following ST-segment elevation acute myocardial infarction. J Am
Coll Cardiol. 63:1593–1603. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shioi T, Matsumori A, Kihara Y, Inoko M,
Ono K, Iwanaga Y, Yamada T, Iwasaki A, Matsushima K and Sasayama S:
Increased expression of interleukin-1 beta and monocyte chemotactic
and activating factor/monocyte chemoattractant protein-1 in the
hypertrophied and failing heart with pressure overload. Circ Res.
81:664–671. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zarrouk-Mahjoub S, Zaghdoudi M, Amira Z,
Chebi H, Khabouchi N, Finsterer J, Mechmeche R and Ghazouani E:
Pro- and anti-inflammatory cytokines in post-infarction left
ventricular remodeling. Int J Cardiol. 221:632–636. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang S, Kotamraju S, Konorev E, Kalivendi
S, Joseph J and Kalyanaraman B: Activation of nuclear factor-kappaB
during doxorubicin-induced apoptosis in endothelial cells and
myocytes is pro-apoptotic: The role of hydrogen peroxide. Biochem
J. 367:729–740. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun B, Xia Q and Gao Z: Total flavones of
choerospondias axillaris attenuate cardiac dysfunction and
myocardial interstitial fibrosis by modulating NF-kB signaling
pathway. Cardiovasc Toxicol. 15:283–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xiao C and Ghosh S: NF-kappaB, an
evolutionarily conserved mediator of immune and inflammatory
responses. Adv Exp Med Biol. 560:41–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zandi E and Karin M: Bridging the gap:
Composition, regulation, and physiological function of the IkappaB
kinase complex. Mol Cell Biol. 19:4547–4551. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tanner H, Mohacsi P, Fuller-Bicer GA,
Rieben R, Meier B, Hess O and Hullin R: Cytokine activation and
disease progression in patients with stable moderate chronic heart
failure. J Heart Lung Transplant. 26:622–629. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elliott PJ, Zollner TM and Boehncke WH:
Proteasome inhibition: A new anti-inflammatory strategy. J Mol Med
(Berl). 81:235–245. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santos DG, Resende MF, Mill JG, Mansur AJ,
Krieger JE and Pereira AC: Nuclear Factor (NF) kappaB polymorphism
is associated with heart function in patients with heart failure.
BMC Med Genet. 11:892010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen FT, Yang CM and Yang CH: The
protective effects of the proteasome inhibitor bortezomib (velcade)
on ischemia-reperfusion injury in the rat retina. PLoS One.
8:e642622013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma Y, Chen B, Liu D, Yang Y, Xiong Z, Zeng
J and Dong Y: MG132 treatment attenuates cardiac remodeling and
dysfunction following aortic banding in rats via the NF-κB/TGFβ1
pathway. Biochem Pharmacol. 81:1228–1236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zimmermann M: Ethical guidelines for
investigations of experimental pain in conscious animals. Pain.
16:109–110. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin JL, Lv RG, Guo J, Liu XH, Liang YW,
Wei JR and Wang L: Improvement of left ventricular remodelling by
inhibition of NF-κB in a rat model of myocardial infarction. Heart
Lung Circ. 25:1007–1012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen ZR, Wu XH, Luo KL, He Q and Xiang YL:
Proteasome inhibitor MG-132 improves myocadial hypertrophy after
myocardial infarction in rats. Basic Clin Med. 32:1326–1331.
2012.(In Chinese).
|
|
16
|
Snyder JG, Prewitt R, Campsen J and Britt
LD: PDTC and Mg132, inhibitors of NF-kappaB, block endotoxin
induced vasodilation of isolated rat skeletal muscle arterioles.
Shock. 17:304–307. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lattouf R, Younes R, Lutomski D, Naaman N,
Godeau G, Senni K and Changotade S: Picrosirius red staining: A
useful tool to appraise collagen networks in normal and
pathological tissues. J Histochem Cytochem. 62:751–758. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang W, Li SN, Huang S and Xu B:
Inhibitor of ubiquitin proteasome system suppress
Calcineurin-dependent cardiomyocyte hypertrophy. Chin J
Arteriosclerosis. 22:774–778. 2014.(In Chinese).
|
|
20
|
Meiners S, Hocher B, Weller A, Laule M,
Stangl V, Guenther C, Godes M, Mrozikiewicz A, Baumann G and Stangl
K: Downregulation of matrix metalloproteinases and collagens and
suppression of cardiac fibrosis by inhibition of the proteasome.
Hypertension. 44:471–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Suo F, Liu J, Hu H, Xue M, Cheng
W, Xuan Y and Yan S: Myocardial infarction induces sympathetic
hyperinnervation via a nuclear factor-κB-dependent pathway in
rabbit hearts. Neurosci Lett. 535:128–133. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li B, Liao YH, Cheng X, Ge H, Guo H and
Wang M: Effects of carvedilol on cardiac cytokines expression and
remodeling in rat with acute myocardial infarction. Int J Cardiol.
111:247–255. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wójcik S, Spodnik JH, Spodnik E,
Dziewiątkowski J and Moryś J: Nigrostriatal pathway degeneration in
rats after intraperitoneal administration of proteasome inhibitor
MG-132. Folia Neuropathol. 52:41–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Sun W, Du B, Miao X, Bai Y, Xin Y,
Tan Y, Cui W, Liu B, Cui T, et al: Therapeutic effect of MG-132 on
diabetic cardiomyopathy is associated with its suppression of
proteasomal activities: Roles of Nrf2 and NF-κB. Am J Physiol Heart
Circ Physiol. 304:H567–H578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen SF, Chen HY, Liu XB, Zhang YX, Liu W,
Wang WH, Zhang B and Wang LX: Apoptotic effect of MG-132 on human
tongue squamous cell carcinoma. Biomed Pharmacother. 65:322–327.
2011. View Article : Google Scholar : PubMed/NCBI
|
